H. Greulich

Computational Theory and Mathematics · 2004–2020

A researcher in the Science corpus: 17 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom H. Greulich trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Randy J. Read
  2. Y. Yarden

Who trusts H. Greulich overall

  1. C. Yun
  2. J. Engelman
  3. William Pao

Papers from H. Greulich's perspective

Ordered by how strongly the researchers H. Greulich trusts endorse each paper. Same corpus, a different order for every researcher.

  1. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
  2. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (Science)
  3. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (PLoS Medicine)
  4. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
  5. Improved methods for building protein models in electron density maps and the location of errors in these models.
  6. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. (Journal of the National Cancer Institute)
  7. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* (Journal of Biological Chemistry)
  8. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (Proceedings of the National Academy of Sciences of the United States of America)
  9. Targeted cancer therapy (Nature)
  10. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (Nature)

Their papers